Dynamic Technology Lab Private LTD Aptinyx Inc. Transaction History

Dynamic Technology Lab Private LTD

  • $885 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$3.0 - $4.08 $40,932 - $55,667
-13,644 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$2.95 - $4.38 $1,324 - $1,966
449 Added 3.4%
13,644 $46,000
Q1 2019

May 13, 2019
BUY
$3.99 - $19.33 $52,648 - $255,059
13,195 New
13,195 $53,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email